Role of vitamin D supplementation in the management of musculoskeletal diseases: update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group.
Chevalley, Thierry; Brandi, Maria Luisa; Cashman, Kevin Det al.
2022 • In Aging Clinical and Experimental Research, 34 (11), p. 2603 - 2623
Falls; Fragility fracture; Osteoarthritis; Vitamin D; Calcifediol; Vitamins; Bone Density Conservation Agents; Humans; Aged; Vitamins/therapeutic use; Dietary Supplements/adverse effects; Vitamin D Deficiency/epidemiology; Osteoporosis/drug therapy; Bone Density Conservation Agents/therapeutic use; Fractures, Bone/prevention & control; Osteoarthritis/drug therapy; Dietary Supplements; Fractures, Bone; Osteoporosis; Vitamin D Deficiency; Aging; Geriatrics and Gerontology
Abstract :
[en] Vitamin D is a key component for optimal growth and for calcium-phosphate homeostasis. Skin photosynthesis is the main source of vitamin D. Limited sun exposure and insufficient dietary vitamin D supply justify vitamin D supplementation in certain age groups. In older adults, recommended doses for vitamin D supplementation vary between 200 and 2000 IU/day, to achieve a goal of circulating 25-hydroxyvitamin D (calcifediol) of at least 50 nmol/L. The target level depends on the population being supplemented, the assessed system, and the outcome. Several recent large randomized trials with oral vitamin D regimens varying between 2000 and 100,000 IU/month and mostly conducted in vitamin D-replete and healthy individuals have failed to detect any efficacy of these approaches for the prevention of fracture and falls. Considering the well-recognized major musculoskeletal disorders associated with severe vitamin D deficiency and taking into account a possible biphasic effects of vitamin D on fracture and fall risks, an European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group convened, carefully reviewed, and analyzed the meta-analyses of randomized controlled trials on the effects of vitamin D on fracture risk, falls or osteoarthritis, and came to the conclusion that 1000 IU daily should be recommended in patients at increased risk of vitamin D deficiency. The group also addressed the identification of patients possibly benefitting from a vitamin D loading dose to achieve early 25-hydroxyvitamin D therapeutic level or from calcifediol administration.
Disciplines :
Public health, health care sciences & services General & internal medicine
Author, co-author :
Chevalley, Thierry ; Service of Bone Diseases, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland. Thierry.chevalley@hcuge.ch
Brandi, Maria Luisa; Metabolic Bone Diseases Unit, Department of Surgery and Translational Medicine, University of Florence, Florence, Italy
Cashman, Kevin D; Cork Centre for Vitamin D and Nutrition Research, School of Food and Nutritional Sciences, University College Cork, Cork, Ireland
Cavalier, Etienne ; Centre Hospitalier Universitaire de Liège - CHU > > Service de chimie clinique
Harvey, Nicholas C; MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, UK ; NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK
Cooper, Cyrus; MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, UK ; NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK ; UKNIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK
Al-Daghri, Nasser; Chair for Biomarkers of Chronic Diseases, Biochemistry Department, College of Science King Saud University, Riyadh, 11451, Saudi Arabia
Bock, Oliver; Department of Osteoporosis, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland ; International Osteoporosis Foundation, Nyon, Switzerland
Bruyère, Olivier ; Division of Public Health, Epidemiology and Health Economics, WHO Collaborating Center for Public Health Aspects of Musculo-Skeletal Health and Ageing, University of Liège, Liege, Belgium
Rosa, Mario Miguel; Centro de Estudos Egas Moniz Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal
Cortet, Bernard; Department of Rheumatology, University of Lille, CHU Lille, MABlab ULR 4490, Lille, France
Cruz-Jentoft, Alfonso J; Servicio de Geriatría, Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain
Cherubini, Antonio; Dipartimento dei percorsi geriatrici della fragilità, Geriatria, Accettazione geriatrica e Centro di ricerca per l'invecchiamentodella continuità di cura e riabilitativi, IRCCS INRCA, Ancona, Italy
Dawson-Hughes, Bess; Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA, USA
Fielding, Roger; Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA, USA
Fuggle, Nicholas; MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, UK ; NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK
Halbout, Philippe; International Osteoporosis Foundation, Nyon, Switzerland
Kanis, John A; Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Sheffield, UK ; Mary McKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia
Kaufman, Jean-Marc; Department of Endocrinology, Ghent University Hospital, Ghent, Belgium
Lamy, Olivier ; Bone Unit, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
Laslop, Andrea; Scientific Office, Federal Office for Safety in Health Care, Austrian Medicines and Medical Devices Agency, Vienna, Austria
Yerro, Maria Concepción Prieto; Spanish Agency for Medicines and Medical Devices, Madrid, Spain
Radermecker, Régis ; Centre Hospitalier Universitaire de Liège - CHU > > Service de diabétologie, nutrition, maladies métaboliques
Thiyagarajan, Jotheeswaran Amuthavalli; Ageing and Health Unit, Department of Maternal, Newborn, Child and Adolescent Health & Ageing, WHO HQ, Geneva, Switzerland
Thomas, Thierry; Department of Rheumatology, North Hospital, CHU Saint-Etienne and INSERM U1059, University of Lyon-University Jean Monnet, Saint-Etienne, France
Veronese, Nicola; Geriatric Unit, Department of Internal Medicine and Geriatrics, University of Palermo, Palermo, Italy
de Wit, Marten; Department of Medical Humanities, Amsterdam University Medical Centre, Amsterdam, The Netherlands
Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique
Rizzoli, René; Service of Bone Diseases, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland
Role of vitamin D supplementation in the management of musculoskeletal diseases: update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group.
Publication date :
November 2022
Journal title :
Aging Clinical and Experimental Research
ISSN :
1594-0667
eISSN :
1720-8319
Publisher :
Springer Science and Business Media Deutschland GmbH, Germany
Munns CF, Shaw N, Kiely M et al (2016) Global consensus recommendations on prevention and management of nutritional rickets. J Clin Endocrinol Metab 101:394–415
Bouillon R, Marcocci C, Carmeliet G et al (2019) Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions. Endocr Rev 40:1109–1151
Bouillon R (2017) Comparative analysis of nutritional guidelines for vitamin D. Nat Rev Endocrinol 13:466–479
Harvey NC, Biver E, Kaufman JM et al (2017) The role of calcium supplementation in healthy musculoskeletal ageing: An expert consensus meeting of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Foundation for Osteoporosis (IOF). Osteoporos Int 28:447–462
Holick MF, Binkley NC, Bischoff-Ferrari HA et al (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1911–1930
Dawson-Hughes B, Mithal A, Bonjour JP et al (2010) IOF position statement: vitamin D recommendations for older adults. Osteoporos Int 21:1151–1154
American Geriatrics Society Workgroup on Vitamin DSfOA (2014) Recommendations abstracted from the American Geriatrics Society Consensus Statement on vitamin D for Prevention of Falls and Their Consequences. J Am Geriatr Soc 62:147–152
Barnsley J, Buckland G, Chan PE et al (2021) Pathophysiology and treatment of osteoporosis: challenges for clinical practice in older people. Aging Clin Exp Res 33:759–773
Khaw KT, Stewart AW, Waayer D et al (2017) Effect of monthly high-dose vitamin D supplementation on falls and non-vertebral fractures: secondary and post-hoc outcomes from the randomised, double-blind, placebo-controlled ViDA trial. Lancet Diabetes Endocrinol 5:438–447
LeBoff MS, Murata EM, Cook NR et al (2020) VITamin D and OmegA-3 TriaL (VITAL): effects of vitamin D supplements on risk of falls in the US population. J Clin Endocrinol Metab 105:2929–2938
LeBoff MS, Chou SH, Ratliff KA et al (2022) Supplemental Vitamin D and Incident Fractures in Midlife and Older Adults. N Engl J Med 387:299–309
MacFarlane LA, Cook NR, Kim E et al (2020) The effects of vitamin D and marine omega-3 fatty acid supplementation on chronic knee pain in older US adults: results from a randomized trial. Arthritis Rheumatol 72:1836–1844
Bischoff-Ferrari HA, Vellas B, Rizzoli R et al (2020) Effect of vitamin D supplementation, omega-3 fatty acid supplementation, or a strength-training exercise program on clinical outcomes in older adults: the DO-HEALTH Randomized Clinical Trial. JAMA 324:1855–1868
Chou SH, Murata EM, Yu C et al (2021) Effects of Vitamin D3 Supplementation on Body Composition in the VITamin D and OmegA-3 TriaL (VITAL). J Clin Endocrinol Metab 106:1377–1388
Bolland MJ, Grey A, Avenell A (2018) Assessment of research waste part 2: wrong study populations- an exemplar of baseline vitamin D status of participants in trials of vitamin D supplementation. BMC Med Res Methodol 18:101
Cauley JA, Greendale GA, Ruppert K et al (2015) Serum 25 hydroxyvitamin D, bone mineral density and fracture risk across the menopause. J Clin Endocrinol Metab 100:2046–2054
Visser M, Deeg DJ, Lips P et al (2003) Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab 88:5766–5772
Rizzoli R, Boonen S, Brandi ML et al (2013) Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Curr Med Res Opin 29:305–313
Cashman KD (2020) Vitamin D deficiency: defining, prevalence, causes, and strategies of addressing. Calcif Tissue Int 106:14–29
Kroll MH, Bi C, Garber CC et al (2015) Temporal relationship between vitamin D status and parathyroid hormone in the United States. PLoS ONE 10:e0118108
Hypponen E, Power C (2007) Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr 85:860–868
Brooks SPJ, Greene-Finestone L, Whiting S et al (2017) An analysis of factors associated with 25-hydroxyvitamin D levels in white and non-white Canadians. J AOAC Int 100:1345–1354
Herrick KA, Storandt RJ, Afful J et al (2019) Vitamin D status in the United States, 2011–2014. Am J Clin Nutr 110:150–157
Cashman KD, Dowling KG, Skrabakova Z et al (2016) Vitamin D deficiency in Europe: pandemic? Am J Clin Nutr 103:1033–1044
Merlijn T, Swart KMA, Lips P et al (2018) Prediction of insufficient serum vitamin D status in older women: a validated model. Osteoporos Int 29:1539–1547
Reid D, Toole BJ, Knox S et al (2011) The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin D concentrations after elective knee arthroplasty. Am J Clin Nutr 93:1006–1011
Vimaleswaran KS, Berry DJ, Lu C et al (2013) Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med 10:e1001383
Crowe FL, Steur M, Allen NE et al (2011) Plasma concentrations of 25-hydroxyvitamin D in meat eaters, fish eaters, vegetarians and vegans: results from the EPIC-Oxford study. Public Health Nutr 14:340–346
O’Neill CM, Kazantzidis A, Ryan MJ et al (2016) Seasonal Changes in Vitamin D-Effective UVB Availability in Europe and Associations with Population Serum 25-Hydroxyvitamin D. Nutrients 8:533
Kazantzidis A, Smedley A, Kift R et al (2015) A modeling approach to determine how much UV radiation is available across the UK and Ireland for health risk and benefit studies. Photochem Photobiol Sci 14:1073–1081
Webb AR (2006) Who, what, where and when-influences on cutaneous vitamin D synthesis. Prog Biophys Mol Biol 92:17–25
Cashman KD (2022) Global differences in vitamin D status and dietary intake: a review of the data. Endocr Connect 11:e210282
Lips P, Cashman KD, Lamberg-Allardt C et al (2019) Current vitamin D status in European and Middle East countries and strategies to prevent vitamin D deficiency: a position statement of the European Calcified Tissue Society. Eur J Endocrinol 180:P23–P54
Allen LdBB, Dary O, Hurrell R (2006) Guidelines on food fortification with micronutrients. World Health Organization and Food and Agriculture Organization of the United Nations. Geneva. http://apps.who.int/iris/bitstream/handle/10665/43412/9241594012_eng.pdf. Accessed 5 Sept 2022
Gallagher JC, Sai A, Templin T 2nd et al (2012) Dose response to vitamin D supplementation in postmenopausal women: a randomized trial. Ann Intern Med 156:425–437
McChesney C, Singer A, Duquette D et al (2022) Do not routinely test for vitamin D. BMJ 378:e070270
Sempos CT, Vesper HW, Phinney KW et al (2012) Vitamin D status as an international issue: national surveys and the problem of standardization. Scand J Clin Lab Invest Suppl 243:32–40
Cavalier E, Lukas P, Bekaert AC et al (2016) Analytical and clinical evaluation of the new Fujirebio Lumipulse(R)G non-competitive assay for 25(OH)-vitamin D and three immunoassays for 25(OH)D in healthy subjects, osteoporotic patients, third trimester pregnant women, healthy African subjects, hemodialyzed and intensive care patients. Clin Chem Lab Med 54:1347–1355
Ginsberg C, Hoofnagle AN, Katz R et al (2021) The Vitamin D metabolite ratio is associated with changes in bone density and fracture risk in older adults. J Bone Miner Res 36:2343–2350
Herrmann M (2020) Towards a personalized assessment of vitamin D status. Clin Chem Lab Med 58:149–151
Cesareo R, Attanasio R, Caputo M et al (2018) Italian Association of Clinical Endocrinologists (AME) and Italian Chapter of the American Association of Clinical Endocrinologists (AACE) Position Statement: Clinical Management of Vitamin D Deficiency in Adults. Nutrients 10:546
Schramm S, Lahner H, Jockel KH et al (2017) Impact of season and different vitamin D thresholds on prevalence of vitamin D deficiency in epidemiological cohorts-a note of caution. Endocrine 56:658–666
Okazaki R, Ozono K, Fukumoto S et al (2017) Assessment criteria for vitamin D deficiency/insufficiency in Japan: proposal by an expert panel supported by the Research Program of Intractable Diseases, Ministry of Health, Labour and Welfare, Japan, the Japanese Society for Bone and Mineral Research and the Japan Endocrine Society [Opinion]. J Bone Miner Metab 35:1–5
Cavalier E, Huyghebaert L, Rousselle O et al (2020) Simultaneous measurement of 25(OH)-vitamin D and 24,25(OH)2-vitamin D to define cut-offs for CYP24A1 mutation and vitamin D deficiency in a population of 1200 young subjects. Clin Chem Lab Med 58:197–201
IOM (2011) Dietary reference intakes for calcium and vitamin D. National Institute of Medicine, Academies Press, Washington DC
Bleicher K, Cumming RG, Naganathan V et al (2014) U-shaped association between serum 25-hydroxyvitamin D and fracture risk in older men: results from the prospective population-based CHAMP study. J Bone Miner Res 29:2024–2031
Avenell A, Mak JC, O’Connell D (2014) Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men. Cochrane Database Syst Rev 4:227
Chapuy MC, Arlot ME, Duboeuf F et al (1992) Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 327:1637–1642
Lyons RA, Johansen A, Brophy S et al (2007) Preventing fractures among older people living in institutional care: a pragmatic randomised double blind placebo controlled trial of vitamin D supplementation. Osteoporos Int 18:811–818
Sanders KM, Stuart AL, Williamson EJ et al (2010) Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 303:1815–1822
Bischoff-Ferrari HA, Willett WC, Wong JB et al (2009) Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med 169:551–561
Lai JK, Lucas RM, Clements MS et al (2010) Hip fracture risk in relation to vitamin D supplementation and serum 25-hydroxyvitamin D levels: a systematic review and meta-analysis of randomised controlled trials and observational studies. BMC Public Health 10:331
Bergman GJ, Fan T, McFetridge JT et al (2010) Efficacy of vitamin D3 supplementation in preventing fractures in elderly women: a meta-analysis. Curr Med Res Opin 26:1193–1201
Chung M, Lee J, Terasawa T et al (2011) Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med 155:827–838
Murad MH, Drake MT, Mullan RJ et al (2012) Clinical review. Comparative effectiveness of drug treatments to prevent fragility fractures: a systematic review and network meta-analysis. J Clin Endocrinol Metab 97:1871–1880
Weaver CM, Alexander DD, Boushey CJ et al (2016) Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation. Osteoporos Int 27:367–376
Zhao JG, Zeng XT, Wang J et al (2017) association between calcium or vitamin D supplementation and fracture incidence in community-dwelling older adults: a systematic review and meta-analysis. JAMA 318:2466–2482
Kahwati LC, Weber RP, Pan H et al (2018) Vitamin D, calcium, or combined supplementation for the primary prevention of fractures in community-dwelling adults: evidence report and systematic review for the US Preventive Services Task Force. JAMA 319:1600–1612
Bolland MJ, Grey A, Avenell A (2018) Effects of vitamin D supplementation on musculoskeletal health: a systematic review, meta-analysis, and trial sequential analysis. Lancet Diabetes Endocrinol 6:847–858
Hu ZC, Tang Q, Sang CM et al (2019) Comparison of fracture risk using different supplemental doses of vitamin D, calcium or their combination: a network meta-analysis of randomised controlled trials. BMJ Open 9:e024595
Yao P, Bennett D, Mafham M et al (2019) Vitamin D and calcium for the prevention of fracture: a systematic review and meta-analysis. JAMA Netw Open 2:e1917789
Eleni A, Panagiotis P (2020) A systematic review and meta-analysis of vitamin D and calcium in preventing osteoporotic fractures. Clin Rheumatol 39:3571–3579
Thanapluetiwong S, Chewcharat A, Takkavatakarn K et al (2020) Vitamin D supplement on prevention of fall and fracture: a Meta-analysis of Randomized Controlled Trials. Medicine (Baltimore) 99:e21506
Li S, Xi C, Li L et al (2021) Comparisons of different vitamin D supplementation for prevention of osteoporotic fractures: a Bayesian network meta-analysis and meta-regression of randomised controlled trials. Int J Food Sci Nutr 72:518–528
Chakhtoura M, Bacha DS, Gharios C et al (2022) Vitamin D supplementation and fractures in adults: a systematic umbrella review of meta-analyses of controlled trials. J Clin Endocrinol Metab 107:882–898
Kong SH, Jang HN, Kim JH et al (2022) Effect of vitamin D supplementation on risk of fractures and falls according to dosage and interval: a meta-analysis. Endocrinol Metab (Seoul) 37:344–358
Smith H, Anderson F, Raphael H et al (2007) Effect of annual intramuscular vitamin D on fracture risk in elderly men and women–a population-based, randomized, double-blind, placebo-controlled trial. Rheumatology (Oxford) 46:1852–1857
WHO (2021) Step safely:strategies for preventing and managing falls across the life-course. Licence:CC BY-NC_SA 30 IGO
Bussell ME (2021) Improving bone health: addressing the burden through an integrated approach. Aging Clin Exp Res 33:2777–2786
Lappe JM, Heaney RP (2012) Why randomized controlled trials of calcium and vitamin D sometimes fail. Dermatoendocrinol 4:95–100
Papadimitropoulos E, Wells G, Shea B et al (2002) Meta-analyses of therapies for postmenopausal osteoporosis. VIII: meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women. Endocr Rev 23:560–569
Wang TJ, Pencina MJ, Booth SL et al (2008) Vitamin D deficiency and risk of cardiovascular disease. Circulation 117:503–511
Shardell M, Cappola AR, Guralnik JM et al (2021) Sex-specific 25-hydroxyvitamin D threshold concentrations for functional outcomes in older adults: PRoject on Optimal VItamin D in Older adults (PROVIDO). Am J Clin Nutr 114:16–28
Gillespie LD, Robertson MC, Gillespie WJ et al (2012) Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev 9:CD007146
LeBlanc ES, Chou R (2015) Vitamin D and falls-fitting new data with current guidelines. JAMA Intern Med 175:712–713
Pfeifer M, Begerow B, Minne HW et al (2000) Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. J Bone Miner Res 15:1113–1118
Cangussu LM, Nahas-Neto J, Orsatti CL et al (2016) Effect of isolated vitamin D supplementation on the rate of falls and postural balance in postmenopausal women fallers: a randomized, double-blind, placebo-controlled trial. Menopause 23:267–274
Ozsoy-Unubol T, Candan Z, Atar E et al (2021) The effect of vitamin D and exercise on balance and fall risk in postmenopausal women: a randomised controlled study. Int J Clin Pract 75:e14851
Prince RL, Austin N, Devine A et al (2008) Effects of ergocalciferol added to calcium on the risk of falls in elderly high-risk women. Arch Intern Med 168:103–108
Pfeifer M, Begerow B, Minne HW et al (2009) Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle function in community-dwelling older individuals. Osteoporos Int 20:315–322
Uusi-Rasi K, Patil R, Karinkanta S et al (2015) Exercise and vitamin D in fall prevention among older women: a randomized clinical trial. JAMA Intern Med 175:703–711
Uusi-Rasi K, Patil R, Karinkanta S et al (2017) A 2-year follow-up after a 2-year RCT with vitamin D and exercise: effects on falls, injurious falls and physical functioning among older women. J Gerontol A Biol Sci Med Sci 72:1239–1245
Patil R, Kolu P, Raitanen J et al (2016) Cost-effectiveness of vitamin D supplementation and exercise in preventing injurious falls among older home-dwelling women: findings from an RCT. Osteoporos Int 27:193–201
Uusi-Rasi K, Patil R, Karinkanta S et al (2019) Serum 25-hydroxyvitamin D levels and incident falls in older women. Osteoporos Int 30:93–101
Wanigatunga AA, Sternberg AL, Blackford AL et al (2021) The effects of vitamin D supplementation on types of falls. J Am Geriatr Soc 69:2851–2864
Karkkainen MK, Tuppurainen M, Salovaara K et al (2010) Does daily vitamin D 800 IU and calcium 1000 mg supplementation decrease the risk of falling in ambulatory women aged 65–71 years? A 3-year randomized population-based trial (OSTPRE-FPS). Maturitas 65:359–365
Hansen KE, Johnson RE, Chambers KR et al (2015) Treatment of vitamin D insufficiency in postmenopausal women: a randomized clinical trial. JAMA Intern Med 175:1612–1621
Bischoff-Ferrari HA, Freystatter G, Vellas B et al (2022) Effects of vitamin D, omega-3 fatty acids, and a simple home strength exercise program on fall prevention: the DO-HEALTH randomized clinical trial. Am J Clin Nutr 115:1311–1321
Appel LJ, Michos ED, Mitchell CM et al (2021) The effects of four doses of vitamin D supplements on falls in older adults: a response-adaptive, randomized clinical trial. Ann Intern Med 174:145–156
Dhesi JK, Jackson SH, Bearne LM et al (2004) Vitamin D supplementation improves neuromuscular function in older people who fall. Age Ageing 33:589–595
Waterhouse M, Sanguineti E, Baxter C et al (2021) Vitamin D supplementation and risk of falling: outcomes from the randomized, placebo-controlled D-Health Trial. J Cachexia Sarcopenia Muscle 12:1428–1439
Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB et al (2009) Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ 339:b3692
Murad MH, Elamin KB, Abu Elnour NO et al (2011) Clinical review: The effect of vitamin D on falls: a systematic review and meta-analysis. J Clin Endocrinol Metab 96:2997–3006
Wu H, Pang Q (2017) The effect of vitamin D and calcium supplementation on falls in older adults: a systematic review and meta-analysis. Orthopade 46:729–736
Guirguis-Blake JM, Michael YL, Perdue LA et al (2018) Interventions to prevent falls in older adults: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA 319:1705–1716
Ling Y, Xu F, Xia X et al (2021) Vitamin D supplementation reduces the risk of fall in the vitamin D deficient elderly: An updated meta-analysis. Clin Nutr 40:5531–5537
Bischoff-Ferrari HA, Orav EJ, Abderhalden L et al (2019) Vitamin D supplementation and musculoskeletal health. Lancet Diabetes Endocrinol 7:85
Dawson-Hughes B, Wang J, Barger K et al (2022) Intra-trial mean 25(OH)D and PTH levels and risk of falling in older men and women in the Boston STOP IT Trial. J Clin Endocrinol Metab 107:e1932–e1937
Bouillon R, Manousaki D, Rosen C et al (2022) The health effects of vitamin D supplementation: evidence from human studies. Nat Rev Endocrinol 18:96–110
Zittermann A, Berthold HK, Pilz S (2021) The effect of vitamin D on fibroblast growth factor 23: a systematic review and meta-analysis of randomized controlled trials. Eur J Clin Nutr 75:980–987
Zittermann A, Berthold HK, PilzSReply to Meshkini, et al (2021) Eur J Clin Nutr 75:990–991
Charoenngam N, Kalajian TA, Shirvani A et al (2021) A pilot-randomized, double-blind crossover trial to evaluate the pharmacokinetics of orally administered 25-hydroxyvitamin D3 and vitamin D3 in healthy adults with differing BMI and in adults with intestinal malabsorption. Am J Clin Nutr 114:1189–1199
Park CY (2019) Vitamin D in the prevention and treatment of osteoarthritis: from clinical interventions to cellular evidence. Nutrients 11:243
Yu Y, Liu D, Feng D et al (2021) Association between Vitamin D and knee osteoarthritis: a PRISMA-compliant meta-analysis. Z Orthop Unfall 159:281–287
Qu Z, Yang F, Yan Y et al (2021) A Mendelian randomization study on the role of serum parathyroid hormone and 25-hydroxyvitamin D in osteoarthritis. Osteoarthritis Cartilage 29:1282–1290
Veronese N, Maggi S, Noale M et al (2015) Serum 25-hydroxyvitamin D and osteoarthritis in older people: the Progetto Veneto Anziani Study. Rejuvenation Res 18:543–553
Gao XR, Chen YS, Deng W (2017) The effect of vitamin D supplementation on knee osteoarthritis: A meta-analysis of randomized controlled trials. Int J Surg 46:14–20
Diao N, Yang B, Yu F (2017) Effect of vitamin D supplementation on knee osteoarthritis: a systematic review and meta-analysis of randomized clinical trials. Clin Biochem 50:1312–1316
Beaudart C, Lengele L, Leclercq V et al (2020) Symptomatic efficacy of pharmacological treatments for knee osteoarthritis: a systematic review and a network meta-analysis with a 6-month time horizon. Drugs 80:1947–1959
Zhao ZX, He Y, Peng LH et al (2021) Does vitamin D improve symptomatic and structural outcomes in knee osteoarthritis? A systematic review and meta-analysis. Aging Clin Exp Res 33:2393–2403
Mathieu S, Soubrier M, Peirs C et al (2022) A meta-analysis of the impact of nutritional supplementation on osteoarthritis symptoms. Nutrients 14:1607
Sanghi D, Mishra A, Sharma AC et al (2013) Does vitamin D improve osteoarthritis of the knee: a randomized controlled pilot trial. Clin Orthop Relat Res 471:3556–3562
Arden NK, Cro S, Sheard S et al (2016) The effect of vitamin D supplementation on knee osteoarthritis, the VIDEO study: a randomised controlled trial. Osteoarthritis Cartilage 24:1858–1866
Chlebowski RT, Pettinger M, Johnson KC et al (2013) Calcium plus vitamin D supplementation and joint symptoms in postmenopausal women in the women’s health initiative randomized trial. J Acad Nutr Diet 113:1302–1310
McAlindon T, LaValley M, Schneider E et al (2013) Effect of vitamin D supplementation on progression of knee pain and cartilage volume loss in patients with symptomatic osteoarthritis: a randomized controlled trial. JAMA 309:155–162
Jin X, Jones G, Cicuttini F et al (2016) Effect of vitamin D supplementation on tibial cartilage volume and knee pain among patients with symptomatic knee osteoarthritis: a randomized clinical trial. JAMA 315:1005–1013
Wang X, Cicuttini F, Jin X et al (2017) Knee effusion-synovitis volume measurement and effects of vitamin D supplementation in patients with knee osteoarthritis. Osteoarthr Cartil 25:1304–1312
Perry TA, Parkes MJ, Hodgson R et al (2019) Effect of Vitamin D supplementation on synovial tissue volume and subchondral bone marrow lesion volume in symptomatic knee osteoarthritis. BMC Musculoskelet Disord 20:76
Ellfolk M, Norlin M, Gyllensten K et al (2009) Regulation of human vitamin D(3) 25-hydroxylases in dermal fibroblasts and prostate cancer LNCaP cells. Mol Pharmacol 75:1392–1399
Haddad JG, Stamp TC (1974) Circulating 25-hydroxyvitamin D in man. Am J Med 57:57–62
Norlin M, Lundqvist J, Ellfolk M et al (2017) Drug-mediated gene regulation of vitamin D3 metabolism in primary human dermal fibroblasts. Basic Clin Pharmacol Toxicol 120:59–63
Jetter A, Egli A, Dawson-Hughes B et al (2014) Pharmacokinetics of oral vitamin D(3) and calcifediol. Bone 59:14–19
Meyer O, Dawson-Hughes B, Sidelnikov E et al (2015) Calcifediol versus vitamin D3 effects on gait speed and trunk sway in young postmenopausal women: a double-blind randomized controlled trial. Osteoporos Int 26:373–381
Perez-Castrillon JL, Duenas-Laita A, Brandi ML et al (2021) Calcifediol is superior to cholecalciferol in improving vitamin D status in postmenopausal women: a randomized trial. J Bone Miner Res 36:1967–1978
Ketteler M, Ambuhl P (2021) Where are we now? Emerging opportunities and challenges in the management of secondary hyperparathyroidism in patients with non-dialysis chronic kidney disease. J Nephrol 34:1405–1418
Cozzolino M, Minghetti P, Navarra P (2022) Extended-release calcifediol in stage 3–4 chronic kidney disease: a new therapy for the treatment of secondary hyperparathyroidism associated with hypovitaminosis D. J Nephrol 35:863–873
Haldimann B, Healy M, Jelliffe R et al (1980) Effect of an oral dose of 25-hydroxyvitamin D3 on its blood levels in patients with the nephrotic syndrome. J Clin Endocrinol Metab 50:470–474
Foresta C, Calogero AE, Lombardo F et al (2015) Late-onset hypogonadism: beyond testosterone. Asian J Androl 17:236–238
Kanter Berga J, Crespo Albiach J, Beltran Catalan S et al (2010) Vitamin D deficiency in a renal transplant population: safe repletion with moderate doses of calcidiol. Transplant Proc 42:2917–2920
Bassatne A, Basbous M, Chakhtoura M et al (2021) The link between COVID-19 and VItamin D (VIVID): a systematic review and meta-analysis. Metabolism 119:154753
Rhein H (2021) Vitamin D-let common sense prevail-on the balance of probabilities. Aging Clin Exp Res 33:2633
Dissanayake HA, de Silva NL, Sumanatilleke M et al (2022) Prognostic and Therapeutic Role of Vitamin D in COVID-19: Systematic Review and Meta-analysis. J Clin Endocrinol Metab 107:1484–1502
Nogues X, Ovejero D, Pineda-Moncusi M et al (2021) Calcifediol treatment and COVID-19-related outcomes. J Clin Endocrinol Metab 106:e4017–e4027
Entrenas Castillo M, Entrenas Costa LM, Vaquero Barrios JM et al (2020) Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study. J Steroid Biochem Mol Biol 203:105751
Alcala-Diaz JF, Limia-Perez L, Gomez-Huelgas R et al (2021) Calcifediol treatment and hospital mortality due to COVID-19: a cohort study. Nutrients 13:1760
Oristrell J, Oliva JC, Casado E et al (2022) Vitamin D supplementation and COVID-19 risk: a population-based, cohort study. J Endocrinol Invest 45:167–179
Sabico S, Enani MA, Sheshah E et al (2021) Effects of a 2-week 5000 IU versus 1000 IU vitamin D3 supplementation on recovery of symptoms in patients with mild to moderate covid-19: a randomized clinical trial. Nutrients 13:2170
De Niet S, Tremege M, Coffiner M et al (2022) Positive effects of vitamin D supplementation in patients hospitalized for COVID-19: a randomized, double-blind, placebo-controlled trial. Nutrients 14:3048
Cianferotti L, Cricelli C, Kanis JA et al (2015) The clinical use of vitamin D metabolites and their potential developments: a position statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF). Endocrine 50:12–26
Sempos CT, Binkley N (2020) 25-Hydroxyvitamin D assay standardisation and vitamin D guidelines paralysis. Public Health Nutr 23:1153–1164
Rizzoli R (2021) Vitamin D supplementation: upper limit for safety revisited? Aging Clin Exp Res 33:19–24
Rizzoli R, Stoermann C, Ammann P et al (1994) Hypercalcemia and hyperosteolysis in vitamin D intoxication: effects of clodronate therapy. Bone 15:193–198
Bischoff-Ferrari HA, Shao A, Dawson-Hughes B et al (2010) Benefit-risk assessment of vitamin D supplementation. Osteoporos Int 21:1121–1132
Smith LM, Gallagher JC, Suiter C (2017) Medium doses of daily vitamin D decrease falls and higher doses of daily vitamin D3 increase falls: a randomized clinical trial. J Steroid Biochem Mol Biol 173:317–322
Bislev LS, LangagergaardRodbro L, Rolighed L et al (2018) Effects of vitamin D3 supplementation on muscle strength, mass, and physical performance in women with vitamin D insufficiency: a randomized placebo-controlled trial. Calcif Tissue Int 103:483–493
Bischoff-Ferrari HA, Orav EJ, Dawson-Hughes B (2016) Estimating vitamin D status and the choice of supplementation dose-reply. JAMA Intern Med 176:865–866
Ginde AA, Blatchford P, Breese K et al (2017) High-dose monthly vitamin D for prevention of acute respiratory infection in older long-term care residents: a randomized clinical trial. J Am Geriatr Soc 65:496–503
Burt LA, Billington EO, Rose MS et al (2019) Effect of high-dose vitamin D supplementation on volumetric bone density and bone strength: a randomized clinical trial. JAMA 322:736–745
Burt LA, Billington EO, Rose MS et al (2020) Adverse effects of high-dose vitamin D supplementation on volumetric bone density are greater in females than males. J Bone Miner Res 35:2404–2414
Ish-Shalom S, Segal E, Salganik T et al (2008) Comparison of daily, weekly, and monthly vitamin D3 in ethanol dosing protocols for two months in elderly hip fracture patients. J Clin Endocrinol Metab 93:3430–3435
Trivedi DP, Doll R, Khaw KT (2003) Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 326:469
Bacon CJ, Gamble GD, Horne AM et al (2009) High-dose oral vitamin D3 supplementation in the elderly. Osteoporos Int 20:1407–1415
Rossini M, Adami S, Viapiana O et al (2012) Dose-dependent short-term effects of single high doses of oral vitamin D(3) on bone turnover markers. Calcif Tissue Int 91:365–369
Heyer FL, de Jong JJ, Willems PC et al (2021) The effect of bolus vitamin D3 supplementation on distal radius fracture healing: a randomized controlled trial using HR-pQCT. J Bone Miner Res 36:1492–1501
Mazess RB, Bischoff-Ferrari HA, Dawson-Hughes B (2021) Vitamin D: bolus is bogus-a narrative review. JBMR Plus 5:e10567